Overview

Tofflon (stock code: 300171) was established in 1993 and listed on the Growth Enterprise Market (GEM) in 2011. Headquartered in Shanghai, Tofflon is a total solution service provider supplying process services and consumables, core equipment, and engineering for global pharmaceutical companies. Tofflon has four core divisions: Bio-process Division, Preparation Equipment Division, Engineering Division, and Food & Beverage Division. Up to now, there are 26 domestic holding subsidiaries such as Tofflon Lifescience and Tofflon Dehui, 13 overseas holding subsidiaries, 8 basic manufacturing bases, and 3 global R&D centers（China, USA, Germany). Tofflon continues to strengthen the research on drug manufacturing and scientific manufacturing of pharma machines and strives to build a "next-generation pharmaceutical manufacturing platform" to provide professional solutions for customers engaged in R&D, pilot, and commercial production, to accelerate drug R&D and large-scale commercial production.